Your browser doesn't support javascript.
loading
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium.
Quiroz, Yakeel T; Solis, Michele; Aranda, María P; Arbaje, Alicia I; Arroyo-Miranda, Mirna; Cabrera, Laura Y; Carrasquillo, Minerva Maria; Corrada, Maria M; Crivelli, Lucia; Diminich, Erica D; Dorsman, Karen A; Gonzales, Mitzi; González, Héctor M; Gonzalez-Seda, Ana L; Grinberg, Lea T; Guerrero, Lourdes R; Hill, Carl V; Jimenez-Velazquez, Ivonne Z; Guerra, Jorge J Llibre; Lopera, Francisco; Maestre, Gladys; Medina, Luis D; O'Bryant, Sid; Peñaloza, Claudia; Pinzon, Maria Mora; Mavarez, Rosa V Pirela; Pluim, Celina F; Raman, Rema; Rascovsky, Katya; Rentz, Dorene M; Reyes, Yarissa; Rosselli, Monica; Tansey, Malú Gámez; Vila-Castelar, Clara; Zuelsdorff, Megan; Carrillo, Maria; Sexton, Claire.
Afiliação
  • Quiroz YT; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Solis M; Freelance science writer, Seattle, Washington, USA.
  • Aranda MP; USC Roybal Institute on Aging, Los Angeles, California, USA.
  • Arbaje AI; Division of Geriatric Medicine and Gerontology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Arroyo-Miranda M; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Cabrera LY; University of Houston, Department of Psychology, Houston, Texas, USA.
  • Carrasquillo MM; The Pennsylvania State University, Department of Engineering Science and Mechanics, University Park, Pennsylvania, USA.
  • Corrada MM; Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Crivelli L; University of California, Irvine, Irvine, California, USA.
  • Diminich ED; Fleni, Department of Cognitive Neurology, Buenos Aires, Argentina.
  • Dorsman KA; Renaissance School of Medicine, Stony Brook, New York, USA.
  • Gonzales M; University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • González HM; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Gonzalez-Seda AL; Department of Neurosciences, University of California, San Diego, San Diego, California, USA.
  • Grinberg LT; Alzheimer's Association, Chicago, Illinois, USA.
  • Guerrero LR; University of California, San Francisco, San Francisco, California, USA.
  • Hill CV; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA.
  • Jimenez-Velazquez IZ; Alzheimer's Association, Chicago, Illinois, USA.
  • Guerra JJL; Medicine Department, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, Puerto Rico, USA.
  • Lopera F; Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
  • Maestre G; Neuroscience Group of Antioquia, University of Antioquia, Medellin, Colombia.
  • Medina LD; University of Texas Rio Grande Valley, Edinburg, Texas, USA.
  • O'Bryant S; University of Houston, Houston, Texas, USA.
  • Peñaloza C; University of North Texas Health Science Center, Fort Worth, Texas, USA.
  • Pinzon MM; Department of Cognition, Development and Educational Psychology, University of Barcelona, Barcelona, Spain.
  • Mavarez RVP; Department of Family Medicine and Community Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Pluim CF; Wisconsin Alzheimer's Institute, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Raman R; University of Texas Rio Grande Valley, School of Medicine, Department of Human Genetics, Edinburg, Texas, USA.
  • Rascovsky K; Rio Grande Valley Alzheimer's Disease Resources Center for Minority Aging Research, University of Texas Rio Grande Valley, School of Medicine, Edinburg, Texas, USA.
  • Rentz DM; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reyes Y; Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
  • Rosselli M; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Tansey MG; Harvard Medical School, Boston, Massachusetts, USA.
  • Vila-Castelar C; Alzheimer's Association, Chicago, Illinois, USA.
  • Zuelsdorff M; Department of Psychology, Florida Atlantic University, Boca Raton, Florida, USA.
  • Carrillo M; University of Florida, Gainesville, Florida, USA.
  • Sexton C; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Alzheimers Dement ; 18(9): 1677-1686, 2022 09.
Article em En | MEDLINE | ID: mdl-35199931
ABSTRACT
The Alzheimer's Association hosted the second Latinos & Alzheimer's Symposium in May 2021. Due to the COVID-19 pandemic, the meeting was held online over 2 days, with virtual presentations, discussions, mentoring sessions, and posters. The Latino population in the United States is projected to have the steepest increase in Alzheimer's disease (AD) in the next 40 years, compared to other ethnic groups. Latinos have increased risk for AD and other dementias, limited access to quality care, and are severely underrepresented in AD and dementia research and clinical trials. The symposium highlighted developments in AD research with Latino populations, including advances in AD biomarkers, and novel cognitive assessments for Spanish-speaking populations, as well as the need to effectively recruit and retain Latinos in clinical research, and how best to deliver health-care services and to aid caregivers of Latinos living with AD.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Alzheimers Dement Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos